

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * tricarboxylic acid cycle (GO:0006099) | 6.15074321 |
| 2 | carnitine shuttle (GO:0006853) | 5.77972326 |
| 3 | * lysine metabolic process (GO:0006553) | 5.75212279 |
| 4 | * lysine catabolic process (GO:0006554) | 5.75212279 |
| 5 | fatty acid transmembrane transport (GO:1902001) | 5.52555043 |
| 6 | 2-oxoglutarate metabolic process (GO:0006103) | 5.31067227 |
| 7 | fatty acid beta-oxidation (GO:0006635) | 5.10123480 |
| 8 | NADH metabolic process (GO:0006734) | 4.98456122 |
| 9 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.78523491 |
| 10 | tricarboxylic acid metabolic process (GO:0072350) | 4.73139305 |
| 11 | amino-acid betaine transport (GO:0015838) | 4.61357515 |
| 12 | carnitine transport (GO:0015879) | 4.61357515 |
| 13 | carnitine transmembrane transport (GO:1902603) | 4.57918268 |
| 14 | regulation of fatty acid oxidation (GO:0046320) | 4.57722312 |
| 15 | regulation of sequestering of triglyceride (GO:0010889) | 4.54122679 |
| 16 | fatty acid oxidation (GO:0019395) | 4.50359286 |
| 17 | * aspartate family amino acid catabolic process (GO:0009068) | 4.45076466 |
| 18 | lipid oxidation (GO:0034440) | 4.39962566 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.38149191 |
| 20 | glyoxylate metabolic process (GO:0046487) | 4.37586855 |
| 21 | fatty acid catabolic process (GO:0009062) | 4.37122772 |
| 22 | oxaloacetate metabolic process (GO:0006107) | 4.32612793 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 4.30686325 |
| 24 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.25398089 |
| 25 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.24958015 |
| 26 | valine metabolic process (GO:0006573) | 4.24395303 |
| 27 | sarcomere organization (GO:0045214) | 4.22581793 |
| 28 | succinate metabolic process (GO:0006105) | 4.15174094 |
| 29 | * acetyl-CoA metabolic process (GO:0006084) | 4.14301158 |
| 30 | short-chain fatty acid metabolic process (GO:0046459) | 4.09915974 |
| 31 | amino-acid betaine metabolic process (GO:0006577) | 4.07313137 |
| 32 | cellular ketone body metabolic process (GO:0046950) | 4.06275248 |
| 33 | positive regulation of fatty acid oxidation (GO:0046321) | 4.04496872 |
| 34 | cell-substrate adherens junction assembly (GO:0007045) | 4.03862858 |
| 35 | focal adhesion assembly (GO:0048041) | 4.03862858 |
| 36 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.02804838 |
| 37 | regulation of cofactor metabolic process (GO:0051193) | 4.02394902 |
| 38 | regulation of coenzyme metabolic process (GO:0051196) | 4.02394902 |
| 39 | carnitine metabolic process (GO:0009437) | 3.99813720 |
| 40 | biotin metabolic process (GO:0006768) | 3.96909253 |
| 41 | protein localization to endosome (GO:0036010) | 3.93770444 |
| 42 | branched-chain amino acid catabolic process (GO:0009083) | 3.92636166 |
| 43 | cardiac myofibril assembly (GO:0055003) | 3.92265358 |
| 44 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.91253316 |
| 45 | L-phenylalanine metabolic process (GO:0006558) | 3.90424660 |
| 46 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.90424660 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 3.89232369 |
| 48 | quaternary ammonium group transport (GO:0015697) | 3.89154855 |
| 49 | adherens junction assembly (GO:0034333) | 3.88122587 |
| 50 | monocarboxylic acid catabolic process (GO:0072329) | 3.88084679 |
| 51 | branched-chain amino acid metabolic process (GO:0009081) | 3.86247450 |
| 52 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.80854820 |
| 53 | L-phenylalanine catabolic process (GO:0006559) | 3.80854820 |
| 54 | kynurenine metabolic process (GO:0070189) | 3.71052829 |
| 55 | cysteine metabolic process (GO:0006534) | 3.70166201 |
| 56 | cell-substrate junction assembly (GO:0007044) | 3.69478011 |
| 57 | Golgi transport vesicle coating (GO:0048200) | 3.59801162 |
| 58 | COPI coating of Golgi vesicle (GO:0048205) | 3.59801162 |
| 59 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.58863804 |
| 60 | ketone body metabolic process (GO:1902224) | 3.53777054 |
| 61 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.52493738 |
| 62 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.48006539 |
| 63 | sulfur amino acid catabolic process (GO:0000098) | 3.40631987 |
| 64 | low-density lipoprotein particle clearance (GO:0034383) | 3.40243106 |
| 65 | positive regulation of lipid catabolic process (GO:0050996) | 3.37563474 |
| 66 | plasma membrane repair (GO:0001778) | 3.36584754 |
| 67 | homocysteine metabolic process (GO:0050667) | 3.36512907 |
| 68 | regulation of early endosome to late endosome transport (GO:2000641) | 3.36210222 |
| 69 | fatty acid homeostasis (GO:0055089) | 3.35449062 |
| 70 | regulation of sulfur metabolic process (GO:0042762) | 3.34266964 |
| 71 | aromatic amino acid family catabolic process (GO:0009074) | 3.32457290 |
| 72 | myofibril assembly (GO:0030239) | 3.32220430 |
| 73 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.31364974 |
| 74 | cardiac muscle contraction (GO:0060048) | 3.23991970 |
| 75 | ethanol oxidation (GO:0006069) | 3.23488020 |
| 76 | actin-myosin filament sliding (GO:0033275) | 3.23252059 |
| 77 | muscle filament sliding (GO:0030049) | 3.23252059 |
| 78 | phospholipid homeostasis (GO:0055091) | 3.22704402 |
| 79 | negative regulation of fatty acid transport (GO:2000192) | 3.18386820 |
| 80 | stress fiber assembly (GO:0043149) | 3.16278441 |
| 81 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.14870710 |
| 82 | 4-hydroxyproline metabolic process (GO:0019471) | 3.14218291 |
| 83 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.14089729 |
| 84 | barbed-end actin filament capping (GO:0051016) | 3.13694324 |
| 85 | serine family amino acid catabolic process (GO:0009071) | 3.12899674 |
| 86 | epithelial cell-cell adhesion (GO:0090136) | 3.12518659 |
| 87 | * carboxylic acid catabolic process (GO:0046395) | 3.12034888 |
| 88 | * organic acid catabolic process (GO:0016054) | 3.12034888 |
| 89 | urea cycle (GO:0000050) | 3.11447857 |
| 90 | urea metabolic process (GO:0019627) | 3.11447857 |
| 91 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.10350235 |
| 92 | cellular modified amino acid catabolic process (GO:0042219) | 3.08316539 |
| 93 | regulation of fatty acid metabolic process (GO:0019217) | 3.07365828 |
| 94 | intracellular lipid transport (GO:0032365) | 3.06748303 |
| 95 | regulation of cholesterol homeostasis (GO:2000188) | 3.06736128 |
| 96 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.05860429 |
| 97 | embryonic process involved in female pregnancy (GO:0060136) | 3.05139097 |
| 98 | * alpha-amino acid catabolic process (GO:1901606) | 3.04152067 |
| 99 | plasma lipoprotein particle clearance (GO:0034381) | 3.03666807 |
| 100 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.01954456 |
| 101 | response to mercury ion (GO:0046689) | 3.01818902 |
| 102 | pinocytosis (GO:0006907) | 3.01745988 |
| 103 | mannose metabolic process (GO:0006013) | 3.00765834 |
| 104 | * cellular amino acid catabolic process (GO:0009063) | 2.97459456 |
| 105 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.97205339 |
| 106 | basement membrane organization (GO:0071711) | 2.95096737 |
| 107 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.95083424 |
| 108 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.94524517 |
| 109 | indole-containing compound catabolic process (GO:0042436) | 2.93604297 |
| 110 | indolalkylamine catabolic process (GO:0046218) | 2.93604297 |
| 111 | tryptophan catabolic process (GO:0006569) | 2.93604297 |
| 112 | bile acid biosynthetic process (GO:0006699) | 2.92850947 |
| 113 | acylglycerol homeostasis (GO:0055090) | 2.92248711 |
| 114 | triglyceride homeostasis (GO:0070328) | 2.92248711 |
| 115 | glutamate metabolic process (GO:0006536) | 2.92141363 |
| 116 | cardiac muscle cell development (GO:0055013) | 2.91656677 |
| 117 | negative regulation of cell size (GO:0045792) | 2.90054098 |
| 118 | thioester biosynthetic process (GO:0035384) | 2.89709641 |
| 119 | acyl-CoA biosynthetic process (GO:0071616) | 2.89709641 |
| 120 | skin morphogenesis (GO:0043589) | 2.88455030 |
| 121 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.86803422 |
| 122 | response to laminar fluid shear stress (GO:0034616) | 2.86625560 |
| 123 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.86520818 |
| 124 | hemidesmosome assembly (GO:0031581) | 2.83324500 |
| 125 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.82391055 |
| 126 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.79219994 |
| 127 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.78398225 |
| 128 | activation of Rac GTPase activity (GO:0032863) | 2.75856489 |
| 129 | apoptotic process involved in morphogenesis (GO:0060561) | 2.75038761 |
| 130 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.69948492 |
| 131 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.58641022 |
| 132 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.57332152 |
| 133 | desmosome organization (GO:0002934) | 2.56960056 |
| 134 | adhesion of symbiont to host (GO:0044406) | 2.55725816 |
| 135 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.55209674 |
| 136 | hypotonic response (GO:0006971) | 2.46741496 |
| 137 | positive regulation of extracellular matrix organization (GO:1903055) | 2.46001498 |
| 138 | activation of MAPKKK activity (GO:0000185) | 2.41497180 |
| 139 | pentose-phosphate shunt (GO:0006098) | 2.40504149 |
| 140 | negative regulation of necroptotic process (GO:0060546) | 2.40420395 |
| 141 | endodermal cell differentiation (GO:0035987) | 2.39954864 |
| 142 | positive regulation of myotube differentiation (GO:0010831) | 2.39035979 |
| 143 | maternal placenta development (GO:0001893) | 2.38623044 |
| 144 | RNA stabilization (GO:0043489) | 2.38052742 |
| 145 | mRNA stabilization (GO:0048255) | 2.38052742 |
| 146 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.37359602 |
| 147 | embryo implantation (GO:0007566) | 2.35500311 |
| 148 | adhesion of symbiont to host cell (GO:0044650) | 2.34642562 |
| 149 | virion attachment to host cell (GO:0019062) | 2.34642562 |
| 150 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.34579268 |
| 151 | modulation by symbiont of host cellular process (GO:0044068) | 2.34322253 |
| 152 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.33701314 |
| 153 | proline biosynthetic process (GO:0006561) | 2.33341831 |
| 154 | regulation of necroptotic process (GO:0060544) | 2.32734159 |
| 155 | regulation of extracellular matrix disassembly (GO:0010715) | 2.32311497 |
| 156 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.30332317 |
| 157 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.30268571 |
| 158 | skeletal muscle adaptation (GO:0043501) | 2.28008080 |
| 159 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.27569040 |
| 160 | protein retention in ER lumen (GO:0006621) | 2.25310454 |
| 161 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.25110590 |
| 162 | positive regulation of receptor recycling (GO:0001921) | 2.24762700 |
| 163 | surfactant homeostasis (GO:0043129) | 2.23731830 |
| 164 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.23615572 |
| 165 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.23543795 |
| 166 | histone H3-K36 demethylation (GO:0070544) | 2.21570919 |
| 167 | cell adhesion mediated by integrin (GO:0033627) | 2.19900730 |
| 168 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.19310349 |
| 169 | apoptotic cell clearance (GO:0043277) | 2.19194512 |
| 170 | mitotic chromosome condensation (GO:0007076) | 2.17834139 |
| 171 | glucose 6-phosphate metabolic process (GO:0051156) | 2.17793399 |
| 172 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.17654215 |
| 173 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.15971782 |
| 174 | hyaluronan catabolic process (GO:0030214) | 2.15872139 |
| 175 | cortical actin cytoskeleton organization (GO:0030866) | 2.14426280 |
| 176 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.14323023 |
| 177 | actin-mediated cell contraction (GO:0070252) | 2.13595436 |
| 178 | ER-nucleus signaling pathway (GO:0006984) | 2.13270647 |
| 179 | positive regulation of nuclease activity (GO:0032075) | 2.13161412 |
| 180 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.13119393 |
| 181 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.12953372 |
| 182 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.12889367 |
| 183 | actin filament-based movement (GO:0030048) | 2.11724666 |
| 184 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.11560104 |
| 185 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.09793219 |
| 186 | atrioventricular valve morphogenesis (GO:0003181) | 2.08619797 |
| 187 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.08094167 |
| 188 | protein targeting to plasma membrane (GO:0072661) | 2.08030866 |
| 189 | membrane protein ectodomain proteolysis (GO:0006509) | 2.07749151 |
| 190 | modulation by virus of host morphology or physiology (GO:0019048) | 2.07089832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.15068784 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.61637282 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.23308538 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.92914863 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.36538276 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.17239551 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.09814695 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.08072064 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.01565024 |
| 10 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.79885195 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.63895157 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.46133221 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.30744646 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.30430682 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.30418917 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.10797469 |
| 17 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.98018490 |
| 18 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.98018490 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.94519243 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.84438864 |
| 21 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.73613027 |
| 22 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.70563494 |
| 23 | KDM2B_26808549_Chip-Seq_K562_Human | 1.63757149 |
| 24 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.61958199 |
| 25 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58149630 |
| 26 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.58017669 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57539934 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.56489986 |
| 29 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.55013687 |
| 30 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.48102591 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47795022 |
| 32 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46219691 |
| 33 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.46074675 |
| 34 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.44882929 |
| 35 | ATF3_27146783_Chip-Seq_COLON_Human | 1.44142562 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.42342079 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.41346283 |
| 38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38827899 |
| 39 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38424426 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.38127183 |
| 41 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37965071 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37334984 |
| 43 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.34894060 |
| 44 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.33531150 |
| 45 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32513537 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32078539 |
| 47 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31088383 |
| 48 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.30586345 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29795680 |
| 50 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.29543242 |
| 51 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27058379 |
| 52 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.23580347 |
| 53 | MYC_22102868_ChIP-Seq_BL_Human | 1.23098695 |
| 54 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.20785728 |
| 55 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20636506 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20496931 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.18144663 |
| 58 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17543607 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16707976 |
| 60 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16530280 |
| 61 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.14160512 |
| 62 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14065202 |
| 63 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14063225 |
| 64 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.13452747 |
| 65 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13244862 |
| 66 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.12886461 |
| 67 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12752944 |
| 68 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.12071449 |
| 69 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11085454 |
| 70 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.10839908 |
| 71 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.10346908 |
| 72 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09986341 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09220659 |
| 74 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.08852826 |
| 75 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.08765638 |
| 76 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08709280 |
| 77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08516758 |
| 78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08255863 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08226449 |
| 80 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08128336 |
| 81 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07644967 |
| 82 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07469886 |
| 83 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07168754 |
| 84 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06933873 |
| 85 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.06882883 |
| 86 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.06124314 |
| 87 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.05194043 |
| 88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03606276 |
| 89 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03488402 |
| 90 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.03336961 |
| 91 | P68_20966046_ChIP-Seq_HELA_Human | 1.03202904 |
| 92 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02758781 |
| 93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.01734922 |
| 94 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.01734922 |
| 95 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01282139 |
| 96 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00823565 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00656681 |
| 98 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98835150 |
| 99 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.98185579 |
| 100 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.97757729 |
| 101 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.96925372 |
| 102 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96163223 |
| 103 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.95934453 |
| 104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95288358 |
| 105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94613666 |
| 106 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94242952 |
| 107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94131490 |
| 108 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92839357 |
| 109 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.92604192 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92282640 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89928814 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89865714 |
| 113 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.88868830 |
| 114 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.88513125 |
| 115 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.87945690 |
| 116 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87455702 |
| 117 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85684677 |
| 118 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85260553 |
| 119 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85216163 |
| 120 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.84378977 |
| 121 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83915695 |
| 122 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.82683812 |
| 123 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81373510 |
| 124 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.81367820 |
| 125 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81349136 |
| 126 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.81111190 |
| 127 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.80442476 |
| 128 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.78652506 |
| 129 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.78356900 |
| 130 | * VDR_21846776_ChIP-Seq_THP-1_Human | 0.76647558 |
| 131 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.76495341 |
| 132 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.76063903 |
| 133 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.75882602 |
| 134 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.75839582 |
| 135 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.75838927 |
| 136 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.74748232 |
| 137 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.74137906 |
| 138 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.73381700 |
| 139 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.72102831 |
| 140 | MAF_26560356_Chip-Seq_TH1_Human | 0.70025719 |
| 141 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.69450865 |
| 142 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.69166042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.60916781 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.54443233 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.09560169 |
| 4 | MP0003646_muscle_fatigue | 3.62994708 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.43563514 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.26387645 |
| 7 | MP0005365_abnormal_bile_salt | 3.09231312 |
| 8 | MP0000751_myopathy | 2.91974468 |
| 9 | MP0004130_abnormal_muscle_cell | 2.90252638 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.67477379 |
| 11 | MP0004215_abnormal_myocardial_fiber | 2.63301567 |
| 12 | MP0005330_cardiomyopathy | 2.58944551 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.57761331 |
| 14 | MP0004036_abnormal_muscle_relaxation | 2.53310801 |
| 15 | MP0005670_abnormal_white_adipose | 2.42159280 |
| 16 | MP0003252_abnormal_bile_duct | 2.37072652 |
| 17 | MP0002877_abnormal_melanocyte_morpholog | 2.32881415 |
| 18 | MP0000749_muscle_degeneration | 2.32735069 |
| 19 | MP0005666_abnormal_adipose_tissue | 2.30507353 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.27435459 |
| 21 | MP0005076_abnormal_cell_differentiation | 2.22523963 |
| 22 | MP0005332_abnormal_amino_acid | 2.20339314 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 2.17985849 |
| 24 | MP0004087_abnormal_muscle_fiber | 2.17795879 |
| 25 | MP0005058_abnormal_lysosome_morphology | 2.12615925 |
| 26 | MP0008775_abnormal_heart_ventricle | 2.01112957 |
| 27 | MP0003091_abnormal_cell_migration | 1.99564468 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 1.98540119 |
| 29 | MP0009840_abnormal_foam_cell | 1.97685195 |
| 30 | MP0002972_abnormal_cardiac_muscle | 1.89348203 |
| 31 | MP0001849_ear_inflammation | 1.82708226 |
| 32 | MP0002269_muscular_atrophy | 1.82639605 |
| 33 | MP0010630_abnormal_cardiac_muscle | 1.79626913 |
| 34 | MP0001544_abnormal_cardiovascular_syste | 1.75561669 |
| 35 | MP0005385_cardiovascular_system_phenoty | 1.75561669 |
| 36 | MP0005409_darkened_coat_color | 1.75438604 |
| 37 | MP0000750_abnormal_muscle_regeneration | 1.75219250 |
| 38 | MP0003453_abnormal_keratinocyte_physiol | 1.74374168 |
| 39 | MP0005257_abnormal_intraocular_pressure | 1.73249345 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.72394161 |
| 41 | MP0005620_abnormal_muscle_contractility | 1.69074182 |
| 42 | MP0003221_abnormal_cardiomyocyte_apopto | 1.67166171 |
| 43 | MP0006138_congestive_heart_failure | 1.65287714 |
| 44 | MP0002118_abnormal_lipid_homeostasis | 1.61347176 |
| 45 | MP0005083_abnormal_biliary_tract | 1.58169341 |
| 46 | MP0002971_abnormal_brown_adipose | 1.57624096 |
| 47 | MP0004858_abnormal_nervous_system | 1.57337944 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.57335283 |
| 49 | MP0000747_muscle_weakness | 1.56749743 |
| 50 | MP0005319_abnormal_enzyme/_coenzyme | 1.55169047 |
| 51 | MP0001348_abnormal_lacrimal_gland | 1.54663403 |
| 52 | MP0005023_abnormal_wound_healing | 1.53324654 |
| 53 | MP0005375_adipose_tissue_phenotype | 1.52142978 |
| 54 | MP0003195_calcinosis | 1.51896544 |
| 55 | MP0001666_abnormal_nutrient_absorption | 1.51050887 |
| 56 | MP0000609_abnormal_liver_physiology | 1.50481673 |
| 57 | MP0001958_emphysema | 1.49983543 |
| 58 | MP0003436_decreased_susceptibility_to | 1.47067876 |
| 59 | MP0002106_abnormal_muscle_physiology | 1.44003715 |
| 60 | MP0003303_peritoneal_inflammation | 1.39388656 |
| 61 | MP0003137_abnormal_impulse_conducting | 1.38028338 |
| 62 | MP0009643_abnormal_urine_homeostasis | 1.37138455 |
| 63 | MP0003950_abnormal_plasma_membrane | 1.36138934 |
| 64 | MP0004947_skin_inflammation | 1.36106071 |
| 65 | MP0002796_impaired_skin_barrier | 1.35215073 |
| 66 | MP0004233_abnormal_muscle_weight | 1.34100546 |
| 67 | MP0004484_altered_response_of | 1.33294312 |
| 68 | MP0000858_altered_metastatic_potential | 1.32597769 |
| 69 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.31287822 |
| 70 | MP0000759_abnormal_skeletal_muscle | 1.28574866 |
| 71 | MP0008961_abnormal_basal_metabolism | 1.27516140 |
| 72 | MP0004043_abnormal_pH_regulation | 1.26886596 |
| 73 | MP0002060_abnormal_skin_morphology | 1.17292175 |
| 74 | MP0000767_abnormal_smooth_muscle | 1.15172851 |
| 75 | MP0002254_reproductive_system_inflammat | 1.14744808 |
| 76 | MP0003566_abnormal_cell_adhesion | 1.14565105 |
| 77 | MP0008260_abnormal_autophagy | 1.11232660 |
| 78 | MP0005369_muscle_phenotype | 1.11162898 |
| 79 | MP0006035_abnormal_mitochondrial_morpho | 1.10866056 |
| 80 | MP0005623_abnormal_meninges_morphology | 1.10797212 |
| 81 | MP0002089_abnormal_postnatal_growth/wei | 1.09798050 |
| 82 | MP0008438_abnormal_cutaneous_collagen | 1.09758082 |
| 83 | MP0002998_abnormal_bone_remodeling | 1.08928872 |
| 84 | MP0004264_abnormal_extraembryonic_tissu | 1.08388965 |
| 85 | MP0002078_abnormal_glucose_homeostasis | 1.07647628 |
| 86 | MP0002896_abnormal_bone_mineralization | 1.05484555 |
| 87 | MP0004085_abnormal_heartbeat | 1.04292575 |
| 88 | MP0001661_extended_life_span | 1.01569053 |
| 89 | MP0004019_abnormal_vitamin_homeostasis | 1.00778639 |
| 90 | MP0005501_abnormal_skin_physiology | 0.97844885 |
| 91 | MP0003941_abnormal_skin_development | 0.97454424 |
| 92 | MP0005266_abnormal_metabolism | 0.97402428 |
| 93 | MP0000003_abnormal_adipose_tissue | 0.96765792 |
| 94 | MP0010368_abnormal_lymphatic_system | 0.96095246 |
| 95 | MP0005535_abnormal_body_temperature | 0.95597968 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.95239707 |
| 97 | MP0003828_pulmonary_edema | 0.93638752 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.93536058 |
| 99 | MP0004145_abnormal_muscle_electrophysio | 0.92931098 |
| 100 | MP0009278_abnormal_bone_marrow | 0.87449610 |
| 101 | MP0001756_abnormal_urination | 0.87240024 |
| 102 | MP0001730_embryonic_growth_arrest | 0.86992698 |
| 103 | MP0005334_abnormal_fat_pad | 0.86956193 |
| 104 | MP0002138_abnormal_hepatobiliary_system | 0.86175608 |
| 105 | MP0000013_abnormal_adipose_tissue | 0.85619056 |
| 106 | MP0000598_abnormal_liver_morphology | 0.85422510 |
| 107 | MP0002970_abnormal_white_adipose | 0.85169278 |
| 108 | MP0002009_preneoplasia | 0.84920976 |
| 109 | MP0004808_abnormal_hematopoietic_stem | 0.83109851 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.83043291 |
| 111 | MP0005451_abnormal_body_composition | 0.81770678 |
| 112 | MP0000685_abnormal_immune_system | 0.81554891 |
| 113 | MP0000266_abnormal_heart_morphology | 0.80931901 |
| 114 | MP0009115_abnormal_fat_cell | 0.80849896 |
| 115 | MP0005621_abnormal_cell_physiology | 0.79189057 |
| 116 | MP0001216_abnormal_epidermal_layer | 0.79159616 |
| 117 | MP0001915_intracranial_hemorrhage | 0.78905466 |
| 118 | MP0003300_gastrointestinal_ulcer | 0.78199612 |
| 119 | MP0000343_altered_response_to | 0.77844247 |
| 120 | MP0003567_abnormal_fetal_cardiomyocyte | 0.75454053 |
| 121 | MP0003763_abnormal_thymus_physiology | 0.74754716 |
| 122 | MP0003448_altered_tumor_morphology | 0.74412627 |
| 123 | MP0003183_abnormal_peptide_metabolism | 0.74125015 |
| 124 | MP0009672_abnormal_birth_weight | 0.73951557 |
| 125 | MP0000467_abnormal_esophagus_morphology | 0.73142592 |
| 126 | MP0005448_abnormal_energy_balance | 0.71059770 |
| 127 | MP0000230_abnormal_systemic_arterial | 0.70504739 |
| 128 | MP0002166_altered_tumor_susceptibility | 0.70290545 |
| 129 | MP0005503_abnormal_tendon_morphology | 0.70127790 |
| 130 | MP0010155_abnormal_intestine_physiology | 0.69412585 |
| 131 | MP0005165_increased_susceptibility_to | 0.69124907 |
| 132 | MP0010234_abnormal_vibrissa_follicle | 0.69086808 |
| 133 | MP0003959_abnormal_lean_body | 0.68271502 |
| 134 | MP0005275_abnormal_skin_tensile | 0.67230727 |
| 135 | MP0003279_aneurysm | 0.67001947 |
| 136 | MP0003186_abnormal_redox_activity | 0.66047792 |
| 137 | MP0004147_increased_porphyrin_level | 0.65821629 |
| 138 | MP0001614_abnormal_blood_vessel | 0.64707403 |
| 139 | MP0009931_abnormal_skin_appearance | 0.63900844 |
| 140 | MP0005636_abnormal_mineral_homeostasis | 0.63490414 |
| 141 | MP0002128_abnormal_blood_circulation | 0.62549205 |
| 142 | MP0009642_abnormal_blood_homeostasis | 0.61848838 |
| 143 | MP0004272_abnormal_basement_membrane | 0.61383523 |
| 144 | MP0002127_abnormal_cardiovascular_syste | 0.61317175 |
| 145 | MP0004510_myositis | 0.60308822 |
| 146 | MP0001765_abnormal_ion_homeostasis | 0.58737801 |
| 147 | MP0009384_cardiac_valve_regurgitation | 0.58109881 |
| 148 | MP0000733_abnormal_muscle_development | 0.55659219 |
| 149 | MP0002136_abnormal_kidney_physiology | 0.54376942 |
| 150 | MP0010352_gastrointestinal_tract_polyps | 0.54230634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myoglobinuria (HP:0002913) | 4.96143571 |
| 2 | Hypoglycemic coma (HP:0001325) | 4.58191403 |
| 3 | Sudden death (HP:0001699) | 4.45615643 |
| 4 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.20742446 |
| 5 | Ketoacidosis (HP:0001993) | 4.19516779 |
| 6 | Hyperglycinuria (HP:0003108) | 4.10937035 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 4.06681172 |
| 8 | Ketosis (HP:0001946) | 4.06291039 |
| 9 | Hyperammonemia (HP:0001987) | 4.01056827 |
| 10 | Rhabdomyolysis (HP:0003201) | 3.94207970 |
| 11 | Protrusio acetabuli (HP:0003179) | 3.91325552 |
| 12 | Exercise-induced myalgia (HP:0003738) | 3.89777021 |
| 13 | Ventricular tachycardia (HP:0004756) | 3.78585806 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.58022752 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 3.58022752 |
| 16 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.53847275 |
| 17 | Dicarboxylic aciduria (HP:0003215) | 3.53847275 |
| 18 | Right ventricular cardiomyopathy (HP:0011663) | 3.43757859 |
| 19 | Premature rupture of membranes (HP:0001788) | 3.30618859 |
| 20 | Xanthomatosis (HP:0000991) | 3.27551347 |
| 21 | Distal lower limb amyotrophy (HP:0008944) | 3.22455884 |
| 22 | Muscle fiber splitting (HP:0003555) | 3.21998543 |
| 23 | Palpitations (HP:0001962) | 3.19587017 |
| 24 | Hyporeflexia of lower limbs (HP:0002600) | 3.16946490 |
| 25 | Lipoatrophy (HP:0100578) | 3.15438881 |
| 26 | Distal lower limb muscle weakness (HP:0009053) | 3.15351423 |
| 27 | Generalized aminoaciduria (HP:0002909) | 3.14507139 |
| 28 | Increased connective tissue (HP:0009025) | 3.13979351 |
| 29 | Deep venous thrombosis (HP:0002625) | 3.13769011 |
| 30 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.11163989 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.10322393 |
| 32 | Calf muscle hypertrophy (HP:0008981) | 3.04996679 |
| 33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.00980103 |
| 34 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.99259741 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 2.98398706 |
| 36 | Hyperacusis (HP:0010780) | 2.89509374 |
| 37 | Atrial fibrillation (HP:0005110) | 2.80743183 |
| 38 | Hyperglycinemia (HP:0002154) | 2.78428773 |
| 39 | Difficulty running (HP:0009046) | 2.78201834 |
| 40 | Dilated cardiomyopathy (HP:0001644) | 2.78037907 |
| 41 | Hypoalphalipoproteinemia (HP:0003233) | 2.77733529 |
| 42 | Intrahepatic cholestasis (HP:0001406) | 2.74745048 |
| 43 | Conjunctival hamartoma (HP:0100780) | 2.72971975 |
| 44 | Muscle fiber inclusion bodies (HP:0100299) | 2.72621745 |
| 45 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.72287651 |
| 46 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.71736537 |
| 47 | Gout (HP:0001997) | 2.70081795 |
| 48 | Proximal tubulopathy (HP:0000114) | 2.68735204 |
| 49 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.65180339 |
| 50 | Spinal rigidity (HP:0003306) | 2.63838038 |
| 51 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.62866493 |
| 52 | Bundle branch block (HP:0011710) | 2.62379378 |
| 53 | Abnormality of the calf musculature (HP:0001430) | 2.62298874 |
| 54 | Primary atrial arrhythmia (HP:0001692) | 2.61952546 |
| 55 | Metabolic acidosis (HP:0001942) | 2.61891084 |
| 56 | Nemaline bodies (HP:0003798) | 2.61830590 |
| 57 | Nausea (HP:0002018) | 2.58075616 |
| 58 | Hepatic necrosis (HP:0002605) | 2.56971300 |
| 59 | Vertebral compression fractures (HP:0002953) | 2.56113463 |
| 60 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.56027425 |
| 61 | Subaortic stenosis (HP:0001682) | 2.53660316 |
| 62 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.53660316 |
| 63 | Flat acetabular roof (HP:0003180) | 2.53589745 |
| 64 | Atrioventricular block (HP:0001678) | 2.53388637 |
| 65 | Supraventricular tachycardia (HP:0004755) | 2.53146786 |
| 66 | Achilles tendon contracture (HP:0001771) | 2.52450207 |
| 67 | Supraventricular arrhythmia (HP:0005115) | 2.51900323 |
| 68 | Hypolipoproteinemia (HP:0010981) | 2.51057135 |
| 69 | Ragged-red muscle fibers (HP:0003200) | 2.44156930 |
| 70 | Syncope (HP:0001279) | 2.43794601 |
| 71 | Increased muscle lipid content (HP:0009058) | 2.42190715 |
| 72 | Ventricular arrhythmia (HP:0004308) | 2.39185807 |
| 73 | Abnormality of proline metabolism (HP:0010907) | 2.37794067 |
| 74 | Hydroxyprolinuria (HP:0003080) | 2.37794067 |
| 75 | Hypobetalipoproteinemia (HP:0003563) | 2.37047003 |
| 76 | Lymphangioma (HP:0100764) | 2.36666424 |
| 77 | Abnormality of purine metabolism (HP:0004352) | 2.36392508 |
| 78 | Cerebral edema (HP:0002181) | 2.35476518 |
| 79 | EMG: myopathic abnormalities (HP:0003458) | 2.34756978 |
| 80 | Cerebral aneurysm (HP:0004944) | 2.33644362 |
| 81 | Abnormality of the Achilles tendon (HP:0005109) | 2.32000010 |
| 82 | Skin nodule (HP:0200036) | 2.30948192 |
| 83 | Cervical subluxation (HP:0003308) | 2.30248597 |
| 84 | Lower limb amyotrophy (HP:0007210) | 2.29921573 |
| 85 | Hyperlipoproteinemia (HP:0010980) | 2.29675791 |
| 86 | Heart block (HP:0012722) | 2.28987857 |
| 87 | Muscle stiffness (HP:0003552) | 2.28893218 |
| 88 | Myopathic facies (HP:0002058) | 2.27044859 |
| 89 | Shallow orbits (HP:0000586) | 2.26534928 |
| 90 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.26410985 |
| 91 | Thin bony cortex (HP:0002753) | 2.24062194 |
| 92 | Vascular tortuosity (HP:0004948) | 2.24033167 |
| 93 | Cholelithiasis (HP:0001081) | 2.23911341 |
| 94 | Difficulty climbing stairs (HP:0003551) | 2.21500668 |
| 95 | Increased purine levels (HP:0004368) | 2.21406393 |
| 96 | Hyperuricemia (HP:0002149) | 2.21406393 |
| 97 | Hamartoma of the eye (HP:0010568) | 2.19943481 |
| 98 | Lethargy (HP:0001254) | 2.19732245 |
| 99 | Abnormal atrioventricular conduction (HP:0005150) | 2.17478467 |
| 100 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.16233206 |
| 101 | Epidermoid cyst (HP:0200040) | 2.16146333 |
| 102 | Aortic aneurysm (HP:0004942) | 2.15382674 |
| 103 | Ankle contracture (HP:0006466) | 2.15301667 |
| 104 | Arterial tortuosity (HP:0005116) | 2.15220441 |
| 105 | Late onset (HP:0003584) | 2.12074007 |
| 106 | Aneurysm (HP:0002617) | 2.10142684 |
| 107 | Vomiting (HP:0002013) | 2.08528987 |
| 108 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.08220783 |
| 109 | Disproportionate tall stature (HP:0001519) | 2.06846647 |
| 110 | Abnormality of serum amino acid levels (HP:0003112) | 2.06813143 |
| 111 | Ulnar bowing (HP:0003031) | 2.06648190 |
| 112 | Broad face (HP:0000283) | 2.06519327 |
| 113 | Ulnar deviation of the wrist (HP:0003049) | 2.04713256 |
| 114 | Abnormal gallbladder morphology (HP:0012437) | 2.03931069 |
| 115 | Round ear (HP:0100830) | 2.03049285 |
| 116 | Complement deficiency (HP:0004431) | 2.02748770 |
| 117 | Type 1 muscle fiber predominance (HP:0003803) | 2.02448691 |
| 118 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.02045938 |
| 119 | Fragile skin (HP:0001030) | 1.99805048 |
| 120 | Abnormality of nucleobase metabolism (HP:0010932) | 1.98741150 |
| 121 | Asymmetry of the thorax (HP:0001555) | 1.98516730 |
| 122 | Esophageal neoplasm (HP:0100751) | 1.97494434 |
| 123 | Neoplasm of head and neck (HP:0012288) | 1.97494434 |
| 124 | Myotonia (HP:0002486) | 1.96770092 |
| 125 | Upper limb amyotrophy (HP:0009129) | 1.96179580 |
| 126 | Distal upper limb amyotrophy (HP:0007149) | 1.96179580 |
| 127 | Neoplasm of the adrenal gland (HP:0100631) | 1.96177924 |
| 128 | Abnormal cartilage morphology (HP:0002763) | 1.96107696 |
| 129 | Bladder diverticulum (HP:0000015) | 1.96015531 |
| 130 | Neonatal death (HP:0003811) | 1.94640624 |
| 131 | Back pain (HP:0003418) | 1.93998626 |
| 132 | Mitral regurgitation (HP:0001653) | 1.93421283 |
| 133 | Osteolytic defects of the hand bones (HP:0009699) | 1.92852491 |
| 134 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.92852491 |
| 135 | Pheochromocytoma (HP:0002666) | 1.91980689 |
| 136 | Hyperglycemia (HP:0003074) | 1.91214490 |
| 137 | Wormian bones (HP:0002645) | 1.90941098 |
| 138 | Increased variability in muscle fiber diameter (HP:0003557) | 1.89634862 |
| 139 | Multiple enchondromatosis (HP:0005701) | 1.88321404 |
| 140 | Blue sclerae (HP:0000592) | 1.87678697 |
| 141 | Spinal cord lesions (HP:0100561) | 1.87150853 |
| 142 | Syringomyelia (HP:0003396) | 1.87150853 |
| 143 | Prolonged QT interval (HP:0001657) | 1.85954185 |
| 144 | Dysmetric saccades (HP:0000641) | 1.85143039 |
| 145 | Atrophic scars (HP:0001075) | 1.84927641 |
| 146 | Hypoglycemic seizures (HP:0002173) | 1.84183463 |
| 147 | Hemorrhage of the eye (HP:0011885) | 1.80675255 |
| 148 | Abnormality of the thoracic spine (HP:0100711) | 1.79117238 |
| 149 | Dilatation of the ascending aorta (HP:0005111) | 1.77119702 |
| 150 | Short nail (HP:0001799) | 1.76673251 |
| 151 | Aortic dissection (HP:0002647) | 1.73644106 |
| 152 | Slender build (HP:0001533) | 1.72583059 |
| 153 | Insomnia (HP:0100785) | 1.72355789 |
| 154 | Generalized amyotrophy (HP:0003700) | 1.72320047 |
| 155 | Neck muscle weakness (HP:0000467) | 1.72209530 |
| 156 | Cerebral inclusion bodies (HP:0100314) | 1.71732822 |
| 157 | Obstructive sleep apnea (HP:0002870) | 1.70684279 |
| 158 | Broad metatarsal (HP:0001783) | 1.69444079 |
| 159 | Persistence of primary teeth (HP:0006335) | 1.69183207 |
| 160 | Myocardial infarction (HP:0001658) | 1.68371914 |
| 161 | Scapular winging (HP:0003691) | 1.68144434 |
| 162 | Long palpebral fissure (HP:0000637) | 1.67031026 |
| 163 | Elbow flexion contracture (HP:0002987) | 1.66454525 |
| 164 | Abnormality of the calcaneus (HP:0008364) | 1.65911939 |
| 165 | Emphysema (HP:0002097) | 1.65300245 |
| 166 | Mitral valve prolapse (HP:0001634) | 1.65112497 |
| 167 | Genu recurvatum (HP:0002816) | 1.64087847 |
| 168 | Gastrointestinal stroma tumor (HP:0100723) | 1.64069083 |
| 169 | Hypercortisolism (HP:0001578) | 1.61546454 |
| 170 | Foot dorsiflexor weakness (HP:0009027) | 1.61501092 |
| 171 | Advanced eruption of teeth (HP:0006288) | 1.61287041 |
| 172 | Progressive muscle weakness (HP:0003323) | 1.59097783 |
| 173 | Coxa vara (HP:0002812) | 1.58333199 |
| 174 | Hyperparathyroidism (HP:0000843) | 1.56717933 |
| 175 | Abnormality of complement system (HP:0005339) | 1.56631158 |
| 176 | Abnormal ossification of hand bones (HP:0005921) | 1.55273243 |
| 177 | Bulbar palsy (HP:0001283) | 1.55034046 |
| 178 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.54817192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.03401909 |
| 2 | PKN2 | 4.46080412 |
| 3 | BCKDK | 4.32055451 |
| 4 | TTN | 4.10463314 |
| 5 | PDK3 | 3.52522620 |
| 6 | PDK4 | 3.52522620 |
| 7 | PRPF4B | 3.21762187 |
| 8 | SMG1 | 3.14665324 |
| 9 | NEK1 | 2.86635851 |
| 10 | CDK12 | 2.77599377 |
| 11 | LMTK2 | 2.59665601 |
| 12 | ERN1 | 2.35927356 |
| 13 | SIK1 | 2.15627044 |
| 14 | IRAK3 | 2.14650535 |
| 15 | OBSCN | 2.07344290 |
| 16 | PDK2 | 1.93336665 |
| 17 | PHKG2 | 1.92636970 |
| 18 | PHKG1 | 1.92636970 |
| 19 | MAP3K13 | 1.92502424 |
| 20 | RIPK1 | 1.89297449 |
| 21 | FLT3 | 1.61667876 |
| 22 | EEF2K | 1.61542519 |
| 23 | MYLK | 1.55922271 |
| 24 | MAP3K10 | 1.54397103 |
| 25 | PTK6 | 1.44042051 |
| 26 | FGFR4 | 1.43880114 |
| 27 | EPHA2 | 1.42387554 |
| 28 | MAP2K3 | 1.38827165 |
| 29 | DMPK | 1.38777548 |
| 30 | MAP3K14 | 1.29232429 |
| 31 | PDGFRA | 1.28497152 |
| 32 | CAMK1D | 1.21049857 |
| 33 | TAOK2 | 1.19550272 |
| 34 | WNK4 | 1.15675808 |
| 35 | MAP3K7 | 1.12861862 |
| 36 | MOS | 1.02316043 |
| 37 | MAPKAPK3 | 0.99554442 |
| 38 | LRRK2 | 0.99281773 |
| 39 | PRKAA2 | 0.96904648 |
| 40 | ILK | 0.95205533 |
| 41 | TIE1 | 0.93704205 |
| 42 | PINK1 | 0.90035113 |
| 43 | PIK3CA | 0.89845217 |
| 44 | DDR2 | 0.89325903 |
| 45 | PRKAA1 | 0.89208046 |
| 46 | LATS1 | 0.88478222 |
| 47 | PAK3 | 0.88304460 |
| 48 | MAP3K9 | 0.87427770 |
| 49 | ARAF | 0.86290364 |
| 50 | MAPK11 | 0.84664732 |
| 51 | KSR2 | 0.81197650 |
| 52 | NME2 | 0.80616694 |
| 53 | RPS6KB2 | 0.80324801 |
| 54 | KDR | 0.78415067 |
| 55 | MAP3K1 | 0.78240230 |
| 56 | RPS6KA2 | 0.77432070 |
| 57 | ZAP70 | 0.77168761 |
| 58 | SCYL2 | 0.75034707 |
| 59 | MAP3K3 | 0.74979270 |
| 60 | RET | 0.73659972 |
| 61 | MTOR | 0.72417725 |
| 62 | LATS2 | 0.72091057 |
| 63 | PRKD1 | 0.71766585 |
| 64 | FGFR3 | 0.71749405 |
| 65 | MST1R | 0.71616198 |
| 66 | NEK9 | 0.71213913 |
| 67 | INSRR | 0.70635185 |
| 68 | MARK2 | 0.70332813 |
| 69 | MELK | 0.70140313 |
| 70 | NTRK1 | 0.68632322 |
| 71 | PRKD2 | 0.68608733 |
| 72 | STK24 | 0.68582006 |
| 73 | CAMK1G | 0.68205159 |
| 74 | MAPK12 | 0.67912519 |
| 75 | MAP2K2 | 0.67833078 |
| 76 | TYRO3 | 0.67200114 |
| 77 | ICK | 0.66825462 |
| 78 | RPS6KL1 | 0.64569939 |
| 79 | RPS6KC1 | 0.64569939 |
| 80 | MAP3K5 | 0.64063631 |
| 81 | MAP2K4 | 0.63846078 |
| 82 | STK38L | 0.63724940 |
| 83 | PDPK1 | 0.62957585 |
| 84 | TAOK1 | 0.62442163 |
| 85 | PRKD3 | 0.61470908 |
| 86 | MAP3K6 | 0.61302443 |
| 87 | PDGFRB | 0.61063553 |
| 88 | PTK2 | 0.60134194 |
| 89 | TYK2 | 0.59844163 |
| 90 | TGFBR2 | 0.58565941 |
| 91 | TESK1 | 0.56046562 |
| 92 | PDK1 | 0.55962749 |
| 93 | PRKCH | 0.55884888 |
| 94 | EPHB1 | 0.55582762 |
| 95 | JAK3 | 0.55266614 |
| 96 | MAP4K1 | 0.55079036 |
| 97 | MAP2K1 | 0.53933593 |
| 98 | JAK2 | 0.53915535 |
| 99 | ROCK1 | 0.52961522 |
| 100 | BMX | 0.52466805 |
| 101 | TBK1 | 0.51395591 |
| 102 | STK38 | 0.50894075 |
| 103 | MAP3K11 | 0.48217053 |
| 104 | CDK4 | 0.48180801 |
| 105 | PRKACG | 0.46592313 |
| 106 | BRAF | 0.46561877 |
| 107 | IRAK4 | 0.46419724 |
| 108 | RPS6KA6 | 0.46388121 |
| 109 | JAK1 | 0.45696558 |
| 110 | PAK4 | 0.45295935 |
| 111 | ABL2 | 0.45124846 |
| 112 | CDK9 | 0.44861711 |
| 113 | DYRK1B | 0.44500911 |
| 114 | EPHB2 | 0.44310109 |
| 115 | AKT2 | 0.43911962 |
| 116 | MAPK7 | 0.43556470 |
| 117 | EPHA3 | 0.43011878 |
| 118 | FGFR1 | 0.42705661 |
| 119 | CDK6 | 0.42602879 |
| 120 | BRD4 | 0.42113240 |
| 121 | CDK7 | 0.40980834 |
| 122 | TESK2 | 0.40801720 |
| 123 | SGK3 | 0.40344105 |
| 124 | STK10 | 0.39967934 |
| 125 | DAPK3 | 0.39352868 |
| 126 | PAK2 | 0.38789786 |
| 127 | ERBB4 | 0.38669436 |
| 128 | HIPK2 | 0.38661651 |
| 129 | RIPK4 | 0.38656670 |
| 130 | MET | 0.38294634 |
| 131 | PRKG2 | 0.37600318 |
| 132 | CDC42BPA | 0.37266035 |
| 133 | MAP3K8 | 0.35771517 |
| 134 | PTK2B | 0.34567553 |
| 135 | CAMKK1 | 0.34377115 |
| 136 | MAP2K6 | 0.32627225 |
| 137 | FER | 0.32606753 |
| 138 | WNK3 | 0.31024861 |
| 139 | GSK3A | 0.30083098 |
| 140 | CAMK4 | 0.29918651 |
| 141 | TRPM7 | 0.29780549 |
| 142 | STK4 | 0.28799511 |
| 143 | RPS6KA1 | 0.28683173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.61001095 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.06000977 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.59617941 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.59363658 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.51117158 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.23589941 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.99666021 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.84723013 |
| 9 | * Carbon metabolism_Homo sapiens_hsa01200 | 2.53840225 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.40998398 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.36473555 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.31892668 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.23721422 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.21899775 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.18473580 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.16957856 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.00570955 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.93013123 |
| 19 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.90181105 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.72541902 |
| 21 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.71710844 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.68542095 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.58654963 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.58503850 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.54100527 |
| 26 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.54085838 |
| 27 | Prion diseases_Homo sapiens_hsa05020 | 1.53755774 |
| 28 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.50717360 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47560180 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.45623959 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.44793223 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.43446647 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.42024002 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.40081418 |
| 35 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.39085032 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.38030546 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.31190016 |
| 38 | Thyroid cancer_Homo sapiens_hsa05216 | 1.30614496 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25544234 |
| 40 | Endometrial cancer_Homo sapiens_hsa05213 | 1.25192026 |
| 41 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.24875256 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24252907 |
| 43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22168723 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.21882160 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21455631 |
| 46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19152400 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.16612788 |
| 48 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.14525937 |
| 49 | Adherens junction_Homo sapiens_hsa04520 | 1.14475460 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12706571 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.09376237 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07935908 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07582944 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07526011 |
| 55 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.06579793 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06399102 |
| 57 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.04705755 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04356918 |
| 59 | * Lysine degradation_Homo sapiens_hsa00310 | 1.04296360 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.03048922 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01942237 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.01512795 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 1.01082402 |
| 64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.00724241 |
| 65 | Prostate cancer_Homo sapiens_hsa05215 | 1.00606939 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00387233 |
| 67 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.98802171 |
| 68 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98673574 |
| 69 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97637840 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.96297786 |
| 71 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.95985405 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.95463820 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95145769 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 0.93891966 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93840742 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.93058159 |
| 77 | Apoptosis_Homo sapiens_hsa04210 | 0.92486671 |
| 78 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.92081218 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90399680 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86906859 |
| 81 | Influenza A_Homo sapiens_hsa05164 | 0.85329535 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.81820039 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81670494 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.80831415 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80356905 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79183594 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78651346 |
| 88 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76313765 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.76299460 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74499252 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.74126841 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73805891 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72448490 |
| 94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72152642 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71116564 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70220228 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70022325 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.69452726 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68632393 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68151951 |
| 101 | Lysosome_Homo sapiens_hsa04142 | 0.67981362 |
| 102 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.67837857 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67563259 |
| 104 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.67271004 |
| 105 | Shigellosis_Homo sapiens_hsa05131 | 0.67169279 |
| 106 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66774249 |
| 107 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66487750 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66216592 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65397350 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65161171 |
| 111 | Leishmaniasis_Homo sapiens_hsa05140 | 0.64596711 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64443097 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61957473 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.61751513 |
| 115 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60765109 |
| 116 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60338951 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60270273 |
| 118 | Parkinsons disease_Homo sapiens_hsa05012 | 0.59566735 |
| 119 | ABC transporters_Homo sapiens_hsa02010 | 0.57232727 |
| 120 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56905458 |
| 121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56263267 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.54368135 |
| 123 | Platelet activation_Homo sapiens_hsa04611 | 0.54064219 |
| 124 | Pathways in cancer_Homo sapiens_hsa05200 | 0.51155651 |
| 125 | Measles_Homo sapiens_hsa05162 | 0.51028905 |
| 126 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49620102 |
| 127 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48531276 |
| 128 | Tight junction_Homo sapiens_hsa04530 | 0.47948536 |
| 129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47747275 |
| 130 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47186498 |
| 131 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45568332 |
| 132 | Salmonella infection_Homo sapiens_hsa05132 | 0.45145083 |
| 133 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40621954 |
| 134 | Viral myocarditis_Homo sapiens_hsa05416 | 0.40596077 |
| 135 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39387312 |
| 136 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38463532 |
| 137 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38280320 |
| 138 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37929216 |
| 139 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37247206 |
| 140 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35580354 |
| 141 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.34752365 |
| 142 | Alzheimers disease_Homo sapiens_hsa05010 | 0.32099634 |
| 143 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31767875 |
| 144 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30712346 |
| 145 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.30578506 |
| 146 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27360910 |
| 147 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27185614 |
| 148 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23529888 |
| 149 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22845331 |
| 150 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21645043 |
| 151 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.20936502 |
| 152 | Focal adhesion_Homo sapiens_hsa04510 | 0.20176233 |
| 153 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.15912125 |
| 154 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.13100812 |
| 155 | Huntingtons disease_Homo sapiens_hsa05016 | 0.12736130 |
| 156 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.12242065 |
| 157 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11580567 |
| 158 | Amoebiasis_Homo sapiens_hsa05146 | 0.09726945 |
| 159 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.09431587 |
| 160 | Bladder cancer_Homo sapiens_hsa05219 | 0.07281558 |
| 161 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.06339205 |
| 162 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.03105310 |

